2023
DOI: 10.1016/j.molstruc.2022.134154
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, in vitro and in silico studies on novel 3-aryloxymethyl-5-[(2-oxo-2-arylethyl)sulfanyl]-1,2,4-triazoles and their oxime derivatives as potent inhibitors of mPGES-1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 78 publications
0
2
0
Order By: Relevance
“…Expression of mPGES-1 enzyme is increased in the presence of inflammation. The design of selective new mPGES-1 inhibitors as anticancer [21][22][23] and anti-inflammatory [24] agents aiming to block PGE2 production by inhibiting the mPGES-1 enzyme remains up-to-date [25].…”
Section: Introductionmentioning
confidence: 99%
“…Expression of mPGES-1 enzyme is increased in the presence of inflammation. The design of selective new mPGES-1 inhibitors as anticancer [21][22][23] and anti-inflammatory [24] agents aiming to block PGE2 production by inhibiting the mPGES-1 enzyme remains up-to-date [25].…”
Section: Introductionmentioning
confidence: 99%
“…It exhibits a wide range of biological activities such as anti-tuberculosis (Küçükgüzel, Küçükgüzel, Rollas, & Kiraz, 2001), anti-inflammatory (Küçükgüzel et al, 2007) and anticancer activities (Kulabaş et al, 2016) due to their ability to easily bind to different macromolecular targets with weak interactions. Moreover, many 1,2,4-triazole-thioether derivatives were evaluated as anticancer (Demirbolat et al, 2022;Kulabaş et al, 2016;Zengin, Unsal Tan, Arafa, & Balkan, 2022) agents whereas several reports indicate them as potential inhibitors of mPGES-1 (Bülbül et al, 2022;Erensoy et al, 2023;He, Li, Liu, & Lai, 2013).…”
Section: Introductionmentioning
confidence: 99%